Previous 10 | Next 10 |
Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company PR Newswire SAN DIEGO , Sept. 22, 2023 /PRNewswire/ -- Sorrento T...
Oramed Announces $101,875,000 Short-Term Senior Secured Note Transaction with Scilex Holding Company PR Newswire 18-month loan with interest rate of SOFR plus 8.5% Oramed receives warrants to purchase up to 17 million shares of Scilex common stock T...
PALO ALTO, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of ac...
2023-09-13 15:45:57 ET More on Oramed, Scilex, etc. Compare metrics for ORMP to SCLX, SRNEQ Scilex: Sorrento's Better Half, Or Its Entangled, Erratic Mover? Sorrento COVID pill meets late-stage trial goal Scilex Holding provides preliminary results for August...
PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento”), an innovative revenue-generating company focused on ac...
2023-08-08 12:05:13 ET More on Oramed and Scilex Scilex: Sorrento's Better Half, Or Its Entangled, Erratic Mover? Oramed: Buyer Beware Scilex announces court order to pause short selling of Sorrento-issued stock Scilex ends rally after postponing annual share...
2023-08-02 08:30:48 ET More on Oramed Oramed: Buyer Beware Oramed's Chinese partner HTIT completes phase 3 oral insulin trial; submits marketing Application in China; stock Up 17% Oramed stock falls 10% as Wainwright cuts rating on potential halt of drug trial ...
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally PR Newswire JV will have global marketing rights to oral drug delivery technology HTIT to invest $60 million , Oramed to invest $10 million int...
2023-06-23 13:11:51 ET Gainers: Ault Alliance ( AULT ) +21% . Smith & Wesson Brands ( SWBI ) +19% . Oncolytics Biotech ( ONCY ) +18% . Lyra Therapeutics ( LYRA ) +19% . Argo Blockchain ( ARBK ) +16% . Golden Heaven Group ...
2023-06-23 10:02:46 ET Gainers: Conformis ( CFMS ) +91% . TRxADE HEALTH ( MEDS ) +11% . Abcam ( ABCM ) +8% . Lexicon Pharmaceuticals ( LXRX ) +4% . Losers: Beyond Air ( XAIR ) -24% . Oramed Pharmaceuticals ( ORMP ) -...
News, Short Squeeze, Breakout and More Instantly...
Oramed Pharmaceuticals Inc. Company Name:
ORMP Stock Symbol:
NASDAQ Market:
Oramed Pharmaceuticals Inc. Website:
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today...
Crescent Energy Company Class A (CRGY) is expected to report $0.21 for Q4 2023 ThredUp Inc. (TDUP) is expected to report $-0.13 for Q4 2023 Wright Investors` Service Holdings Inc (IWSH) is expected to report for Q4 2023 Bridgford Foods Corporation (BRID) is expected to report for Q1 2...